TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
RCEL

Avita Medical Ltd

Healthcare · Medical Devices

12.70$ +5.4% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow RCEL
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2022 2023 2024 2025
-543.7% -546.6% -760.0% – -510.2% -421.5% -54.6% – -55.5% -75.8% -76.2% -43.6%
6.2% 9.1% 6.5% – 7.1% 8.6% 2.9% – 1.7% 1.3% 1.8% 2.8%
71.2% 103.3% 115.4% – 51.6% 307.5% 19.2% – 20.3% 16.7% 21.0% 13.3%
37.7% 103.0% 29.1% – 42.8% 324.1% 20.7% – 22.8% – – –
-55.9% 79.8% -48.7% – 86.7% 24.6% -5.2% – -3.5% -13.1% -7.3% 4.8%
3.5% 27.6% 21.4% – 27.9% 15.7% 1.5% – 1.5% 2.9% 14.5% 2.4%
-3.5% 12.5% -21.4% – -34.0% -15.7% -152.0% – -56.2% 3.2% 58.2% 17.4%
0.0% 0.0% 0.0% – 0.0% – – – – – – –
-49.5% -32.9% -107.1% – 22.7% – – – – – – –
0.0% -4.0% -3.6% – -1.1% -0.8% 0.0% – 0.0% 77.3% 0.0% –
680.0% 526.2% 1,248.8% – 787.4% 1,427.9% 194.0% – 2.6% 80.5% 5.5% 20.9%
135.9% -16.5% 473.4% – 248.8% 990.8% 112.4% – -109.1% 7.9% -12.6% -5.3%
-547.2% -574.2% -781.4% – -549.0% -437.2% -56.1% – -57.0% -78.7% -90.7% -46.0%

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?